Deep vein thrombosis
366 results
135 - 234
Sulodexide given long-term may reduce recurrent VTE in patients with initial unprovoked VTE
Prevention of venous thromboembolism - Venous insufficiency of the lower limbs
- Whether warfarin is taken in the morning or the evening makes no meaningful difference in time in therapeutic range
- Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction)
- Baker's cyst
Interventions for preventing venous thromboembolism following abdominal aortic surgery- Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism
- Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents
- Antithrombotic agents in primary health care
- Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
- Thrombophilia testing for prevention of recurrent venous thromboembolism
- Leg oedema
- Thromboembolism recurrence likely; consider it a chronic disease (MARVELOUS)
- Wells score not helpful in hospitalized patients with suspected DVT
- Anticoagulants for acute ischaemic stroke
- Heparin for pregnant women with acquired or inherited thrombophilias
- Genotype-guided perioperative warfarin dosing may not be superior to algorithm-guided dosing
- Clinical rule to identify patients at low risk of recurrent VTE
- Warfarin therapy
- Patients with initial unprovoked DVT or PE benefit from long-term low-dose aspirin (INSPIRE)
- Statins for primary prevention of venous thromboembolism: Cochrane systematic review
- Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery: Cochrane systematic review
- CHIVA method for the treatment of chronic venous insufficiency
- Evaluation of thrombophilia
- Outcomes after displaced fractures of the femoral neck
- Anticoagulants for people hospitalised with COVID‐19
- Simple fibula fractures can be treated with splinting
- Guidelines for managing VTE (AAFP, ACP)
- Pulmonary embolism
- Serial proximal vein ultrasonography + D-dimer = whole-leg Doppler for suspected leg DVT
- Compression stockings ineffective after DVT
- COVID-19 research briefs: High incidence of thrombotic events in patients hospitalized with COVID-19
- Low-dose aspirin not useful for venous ulcers
- Are inferior vena cava filters overused?
- IPC safer and as effective as medical prophylaxis; much better than TEDS
- Cerebral infarction (ischaemic stroke)
- Anaesthesia for hip fracture surgery in adults
- Antiplatelet agents for the treatment of deep venous thrombosis
- Dabigatran safe and effective for VTE
- Low rate of symptomatic VTE after elective knee arthroscopy
- Early endovenous ablation improves outcomes in patients with venous leg ulcers
- Neuromuscular electrical stimulation for the prevention of venous thromboembolism
- Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
- Updated American College of Chest Physicians guideline on antithrombotic therapy for venous thromboembolism
- Prolonged fever in the adult
- Surgery for deep venous insufficiency
- Topical application of tranexamic acid for the reduction of bleeding: Cochrane systematic review
- Compression therapy for prevention of post-thrombotic syndrome
- Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
- Dabigatran versus LMWHs for thromboprophylaxis after total hip or knee replacement
- Obesity not associated with adverse hip replacement outcomes
- Joint lavage for osteoarthritis of the knee: Cochrane systematic review
- Lower leg fractures
- Topical application of tranexamic acid for the reduction of bleeding
- Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
- Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO)
- Idarucizumab can reverse anticoagulation of dabigatran
- Methods for administering subcutaneous heparin during pregnancy: Cochrane systematic review
- Anticoagulation for perioperative thromboprophylaxis in people with cancer
- Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period
- Vena caval filters for the prevention of pulmonary embolism
- Tranexamic acid may reduce bleeding after cesarean delivery, but with a risk of adverse effects
- Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE
- Thromboprophylaxis for trauma patients: Cochrane systematic review
- Aspirin no different than rivaroxaban for prevention of VTE after TKA or THA
- Simple risk score predicts severity of COPD exacerbations
- Simple risk model predicts risk of VTE after surgery
- Anticoagulants versus non‐steroidal anti‐inflammatories or placebo for treatment of venous thromboembolism
- Antithrombotic treatment after stroke due to intracerebral haemorrhage
- Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
- Treatment for femoral pseudoaneurysms: Cochrane systematic review
- Sclerotherapy for varicose veins
- Surgery or lasers preferred to foam sclerotherapy for varicose veins
- Risk prediction model predicts VTE recurrence after initial thrombotic event
- Overweight in pregnancy
- Preoperative education for hip or knee replacement: Cochrane systematic review
- Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
- Total knee replacement more effective for pain and function than nonsurgical treatment
- Prophylactic anticoagulants for non‐hospitalised people with COVID‐19
- Edoxaban as effective as LMWH for treatment of cancer-associated VTE
- SR: poor-quality data suggests stem cell joint injections are safe, but of unclear benefit
- Routine CT scans for occult malignancy not useful in patients with unprovoked VTE
- Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
- Interventions for varicose veins and leg oedema in pregnancy